AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7542818 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual laser ablation of the prostate (VLAP)
Number of subjects: 115
Study 7542818 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 115
Study 2523291 — intervention group
Group type: EXPERIMENTAL
Intervention: Two additional puffs of ipratropium bromide (IPR) after baseline spirometry
Number of subjects: 12
Study 2523291 — intervention group
Group type: EXPERIMENTAL
Intervention: Two puffs of metaproterenol (META) after baseline spirometry
Number of subjects: 12
Study 2523291 — intervention group
Group type: COMPARATOR
Intervention: Two puffs of placebo after baseline spirometry
Number of subjects: 12
Study 31864382 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal education
Number of subjects: 120
Study 31864382 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program developed by pediatric allergy specialists
Number of subjects: 120
Study 31188762 — intervention group
Group type: COMPARATOR
Intervention: Corin
Number of subjects: 40
Study 31188762 — intervention group
Group type: COMPARATOR
Intervention: PI of uterine arteries
Number of subjects: 40
Study 31188762 — intervention group
Group type: COMPARATOR
Intervention: APGAR score and birth weight
Number of subjects: 40
Study 31188762 — intervention group
Group type: COMPARATOR
Intervention: sEndoglin, sFlt-1, PP13
Number of subjects: 40
Study 27113876 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-fluidics configuration (Centurion Vision System with Active Fluidics)
Number of subjects: 200
Study 27113876 — intervention group
Group type: COMPARATOR
Intervention: Gravity-fluidics configuration (Infiniti Vision System with gravity fluidics)
Number of subjects: 200
Study 27113876 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-fluidics configuration
Number of subjects: 200
Study 27113876 — intervention group
Group type: COMPARATOR
Intervention: Gravity-fluidics configuration
Number of subjects: 200
Study 25163444 — intervention group
Group type: EXPERIMENTAL
Intervention: 3‐mg melatonin
Number of subjects: 0
Study 25163444 — intervention group
Group type: COMPARATOR
Intervention: 5‐mg melatonin
Number of subjects: 0
Study 25163444 — intervention group
Group type: COMPARATOR
Intervention: Baseline (before melatonin administration)
Number of subjects: 0
Study 22285095 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2mg estriol
Number of subjects: 436
Study 22285095 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03mg estriol
Number of subjects: 436
Study 22285095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 436
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI (irinotecan plus infusional 5-fluorouracil and leucovorin)
Number of subjects: 547
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: mIFL (irinotecan plus bolus 5-fluorouracil/leucovorin)
Number of subjects: 547
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: CapeIRI (irinotecan plus oral capecitabine)
Number of subjects: 547
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI with bevacizumab
Number of subjects: 547
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: mIFL with bevacizumab
Number of subjects: 547
Study 19382200 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 547
Study 19382200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study 18633170 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg)
Number of subjects: 56
Study 18633170 — intervention group
Group type: COMPARATOR
Intervention: Candesartan (8 mg)
Number of subjects: 56
Study 18633170 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan (in vitro)
Number of subjects: 56
Study 18633170 — intervention group
Group type: COMPARATOR
Intervention: Candesartan (in vitro)
Number of subjects: 56
Study 15894688 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 63 g of sugars for 10 days
Number of subjects: 21
Study 15894688 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 143 g of sugars for 10 days
Number of subjects: 21
Study 15894688 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 264 g of sugars for 10 days
Number of subjects: 21
Study 15894688 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual diet for 30 days
Number of subjects: 21
Study 12373465 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous renal replacement therapy (CRRT)
Number of subjects: 587
Study 12373465 — intervention group
Group type: COMPARATOR
Intervention: Intermittent renal replacement therapy (IRRT)
Number of subjects: 587
Study 10071295 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer touch-screen questionnaires
Number of subjects: 149
Study 10071295 — intervention group
Group type: COMPARATOR
Intervention: Paper questionnaires scanned by optical reading systems
Number of subjects: 149
Study 10071295 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic version of the questionnaires (test-retest)
Number of subjects: 149
Study 7549808 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy restriction (80% of estimated weight-maintaining energy)
Number of subjects: 24
Study 7549808 — intervention group
Group type: COMPARATOR
Intervention: Control (100% of estimated weight-maintaining energy)
Number of subjects: 24
Study 1993815 — intervention group
Group type: EXPERIMENTAL
Intervention: American cockroach whole body extracts (ACWBE)
Number of subjects: 69
Study 1993815 — intervention group
Group type: EXPERIMENTAL
Intervention: German cockroach whole body extracts (GWBEs)
Number of subjects: 69
Study 1993815 — intervention group
Group type: EXPERIMENTAL
Intervention: German cockroach fecal extracts (GFEs)
Number of subjects: 69
Study 1993815 — intervention group
Group type: EXPERIMENTAL
Intervention: RAST inhibition with GFEs
Number of subjects: 69
Study 7095978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal cocaine hydrochloride (0.2 mg/kg)
Number of subjects: 4
Study 7095978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal cocaine hydrochloride (0.75 mg/kg)
Number of subjects: 4
Study 7095978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal cocaine hydrochloride (1.5 mg/kg)
Number of subjects: 4
Study 7095978 — intervention group
Group type: COMPARATOR
Intervention: Intranasal lidocaine hydrochloride (0.2 mg/kg)
Number of subjects: 4
Study 31399906 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib 250 mg/day during chemotherapy interval and as maintenance therapy
Number of subjects: 24
Study 31614909 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyewash solution (preservative-free)
Number of subjects: 21
Study 31614909 — intervention group
Group type: COMPARATOR
Intervention: Nonwash follow up group (control)
Number of subjects: 21
Study 28103075 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based multilevel HBV screening intervention
Number of subjects: 2337
Study 28103075 — intervention group
Group type: COMPARATOR
Intervention: General cancer education program (control)
Number of subjects: 2337
Study 25034618 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine adipate/valsartan
Number of subjects: 44
Study 25034618 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine besylate/valsartan
Number of subjects: 44
Study 25034618 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 44
Study 23660289 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial tirofiban infusion
Number of subjects: 22
Study 23660289 — intervention group
Group type: COMPARATOR
Intervention: Intra-arterial abciximab infusion
Number of subjects: 22
Study 23660289 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 22
Study 21354925 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib (40 mg)
Number of subjects: 100
Study 21354925 — intervention group
Group type: COMPARATOR
Intervention: PCA with morphine doses at 0 mg (P(1))
Number of subjects: 100
Study 21354925 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with morphine doses at 5 mg (P(2))
Number of subjects: 100
Study 21354925 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with morphine doses at 10 mg (P(3))
Number of subjects: 100
Study 21354925 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with morphine doses at 15 mg (P(4))
Number of subjects: 100
Study 21354925 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA with morphine doses at 20 mg (P(5))
Number of subjects: 100
Study 19633834 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic thrombolysis with rtPA and tirofiban
Number of subjects: 103
Study 19633834 — intervention group
Group type: COMPARATOR
Intervention: Failed recanalization
Number of subjects: 103
Study 17556628 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of azithromycin, ivermectin, and albendazole
Number of subjects: 18
Study 17556628 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin alone
Number of subjects: 18
Study 17556628 — intervention group
Group type: COMPARATOR
Intervention: Ivermectin and albendazole combination
Number of subjects: 18
Study 15167732 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincisional retrobulbar injection containing bupivacaine, lidocaine, epinephrine, and hyaluronidase
Number of subjects: 69
Study 15167732 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving saline placebo
Number of subjects: 69
Study 11677191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine treatment for 2 weeks
Number of subjects: 77
Study 11677191 — intervention group
Group type: COMPARATOR
Intervention: Control group without exposure to bodies of water
Number of subjects: 77
Study 11677191 — intervention group
Group type: COMPARATOR
Intervention: Control group with exposure to marine waters
Number of subjects: 77
Study 11677191 — intervention group
Group type: COMPARATOR
Intervention: Repeated VCS testing alone
Number of subjects: 77
Study 11677191 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine treatment in patients with elevated cholesterol levels
Number of subjects: 77
Study 9749566 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH in hypopituitarism patients
Number of subjects: 2
Study 9749566 — intervention group
Group type: COMPARATOR
Intervention: Normal cycle women
Number of subjects: 2
Study 9749566 — intervention group
Group type: COMPARATOR
Intervention: Postmenopausal women
Number of subjects: 2
Study 7786693 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate therapy (1.0 g bolus followed by 1.0 g every hour for three hours, then 1.0 g every 6 hours for 24 hours)
Number of subjects: 105
Study 7786693 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium sulphate therapy)
Number of subjects: 105
Study 7786693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 105
Study 3057900 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-cholera toxin bovine colostral immunoglobulins (2 g in 100 ml of water, two doses in Trial I; 2 g every two hours for a total of eight doses in Trial II)
Number of subjects: 65
Study 3057900 — intervention group
Group type: COMPARATOR
Intervention: Non-immune bovine colostral immunoglobulins (two doses in Trial I; 2 g every two hours for a total of eight doses in Trial II)
Number of subjects: 65
Study 3057900 — intervention group
Group type: COMPARATOR
Intervention: Water (100 ml alone in Trial I; 100 ml every two hours for a total of eight doses in Trial II)
Number of subjects: 65
Study 29669079 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended-learning Pain Neuroscience Education (PNE)
Number of subjects: 120
Study 29669079 — intervention group
Group type: COMPARATOR
Intervention: Biomedically focused back/neck school education
Number of subjects: 120
Study 26991489 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Controlled Anesthetic Delivery System (CNR)
Number of subjects: 31
Study 26991489 — intervention group
Group type: COMPARATOR
Intervention: Conventional Local Anesthetic Technique (CNV)
Number of subjects: 31
Study 25199526 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (2x/week for 12 weeks)
Number of subjects: 0
Study 25199526 — intervention group
Group type: COMPARATOR
Intervention: Physical Therapy (2x/week for 6 weeks, followed by 6 weeks of monitored home exercise)
Number of subjects: 0
Study 23869682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive allied health assessment/intervention by at least one professional in a care coordination team
Number of subjects: 2121
Study 23869682 — intervention group
Group type: COMPARATOR
Intervention: No assessment (control group)
Number of subjects: 2121
Study 23869682 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive allied health assessment/intervention
Number of subjects: 2121
Study 19959168 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglustat therapy
Number of subjects: 26
Study 19090871 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer
Number of subjects: 2103
Study 19090871 — intervention group
Group type: COMPARATOR
Intervention: Calcium-based binders
Number of subjects: 2103
Study 16280273 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring (SM)
Number of subjects: 269
Study 16280273 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 269
Study 12113318 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasound-guided SPA
Number of subjects: 60
Study 12113318 — intervention group
Group type: COMPARATOR
Intervention: Conventional blind SPA with prehydration protocol
Number of subjects: 60
Study 10534727 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B vaccine (20 microg/dose) given in months 0, 1, and 6 to group I (26 patients)
Number of subjects: 91
Study 10534727 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant hepatitis B vaccine (20 microg/dose) given in months 0, 1, and 6 to group II (35 healthy subjects)
Number of subjects: 91
Study 10534727 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group III, 30 patients with chronic hepatitis C)
Number of subjects: 91
Study 7785755 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia (1.0-2.5 mg/kg for induction, 4-12 mg/kg for maintenance)
Number of subjects: 93
Study 7785755 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane anesthesia (methohexital 1-2 mg/kg for induction, isoflurane 0.4-2.0 vol% for maintenance)
Number of subjects: 93
Study 2152066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cared for with their mothers in the postnatal wards
Number of subjects: 392
Study 2152066 — intervention group
Group type: COMPARATOR
Intervention: Admitted to the special care nursery
Number of subjects: 392
Study 6246620 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8
Study 6246620 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 8
Study 6246620 — intervention group
Group type: EXPERIMENTAL
Intervention: Practolol
Number of subjects: 8
Study 6246620 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31117097 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry + Propolis (DUAB)
Number of subjects: 85
Study 31117097 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 28898379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node dissection (SLND) alone
Number of subjects: 891
Study 28898379 — intervention group
Group type: COMPARATOR
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 891
Study 25524751 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic care management (CCM)
Number of subjects: 282
Study 23478273 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT)
Number of subjects: 20
Study 21088117 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercises (SE)
Number of subjects: 104
Study 21088117 — intervention group
Group type: COMPARATOR
Intervention: Radial extracorporeal shock-wave therapy (rESWT)
Number of subjects: 104
Study 18727949 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with schizophrenia
Number of subjects: 36
Study 18727949 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control)
Number of subjects: 36
Study 17241507 — intervention group
Group type: EXPERIMENTAL
Intervention: mivacurium (0.15 mg kg(‐1))
Number of subjects: 50
Study 17241507 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium (0.3 mg kg(‐1))
Number of subjects: 50
Study 14752617 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g/day)
Number of subjects: 25
Study 14752617 — intervention group
Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 25
Study 11451594 — intervention group
Group type: COMPARATOR
Intervention: Superficial burns
Number of subjects: 5
Study 11451594 — intervention group
Group type: COMPARATOR
Intervention: Deeper burns
Number of subjects: 5
Study 9734576 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant psychological group therapy
Number of subjects: 303
Study 9734576 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 303
Study 8291822 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg, once daily
Number of subjects: 16
Study 8291822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 3397588 — intervention group
Group type: EXPERIMENTAL
Intervention: iso-osmolar test solutions
Number of subjects: 20
Study 3397588 — intervention group
Group type: EXPERIMENTAL
Intervention: hyperosmolar test solutions
Number of subjects: 20
Study 3397588 — intervention group
Group type: EXPERIMENTAL
Intervention: D-xylose absorption
Number of subjects: 20
Study 3397588 — intervention group
Group type: EXPERIMENTAL
Intervention: lactulose and L-rhamnose permeation
Number of subjects: 20
Study 3397588 — intervention group
Group type: COMPARATOR
Intervention: healthy adult volunteers
Number of subjects: 20
Study 29617836 — intervention group
Group type: EXPERIMENTAL
Intervention: Crizotinib
Number of subjects: 86
Study 29617836 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study 29617836 — intervention group
Group type: EXPERIMENTAL
Intervention: MET overexpression in OL
Number of subjects: 86
Study 28624326 — intervention group
Group type: EXPERIMENTAL
Intervention: Illuminated microcatheter-assisted circumferential trabeculotomy (IMCT)
Number of subjects: 31
Study 28624326 — intervention group
Group type: COMPARATOR
Intervention: Conventional partial trabeculotomy (CPT)
Number of subjects: 31
Study 25782761 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate CBT (n=18)
Number of subjects: 38
Study 25782761 — intervention group
Group type: COMPARATOR
Intervention: Delayed CBT (n=20)
Number of subjects: 38
Study 25154151 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg once daily
Number of subjects: 360
Study 25154151 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg once daily
Number of subjects: 360
Study 21507036 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate cream and coal tar daily for 16 weeks
Number of subjects: 52
Study 21507036 — intervention group
Group type: COMPARATOR
Intervention: Topical PUVAsol on alternate days for 16 weeks
Number of subjects: 52
Study 18334511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibandronate 6 mg infused over 15 min
Number of subjects: 130
Study 18334511 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate 6 mg infused over 60 min
Number of subjects: 130
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RTOG score 0
Number of subjects: 42
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RTOG score 1
Number of subjects: 42
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RTOG score 2
Number of subjects: 42
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with RTOG score 3
Number of subjects: 42
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Xerostomia group (salivary flow < 0.2 ml/min)
Number of subjects: 42
Study 16703289 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonxerostomia group (salivary flow > 0.2 ml/min)
Number of subjects: 42
Study 16703289 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients who had not received radiotherapy)
Number of subjects: 42
Study 12920037 — intervention group
Group type: EXPERIMENTAL
Intervention: ACVBP (doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone)
Number of subjects: 635
Study 12920037 — intervention group
Group type: COMPARATOR
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 635
Study 12920037 — intervention group
Group type: EXPERIMENTAL
Intervention: ACVBP
Number of subjects: 635
Study 12920037 — intervention group
Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 635
Study 10718161 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine (150 mg/day median dose)
Number of subjects: 13
Study 10718161 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly relapse prevention therapy
Number of subjects: 13
Study 9384333 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 54
Study 9384333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 1316779 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin, etoposide, and ifosfamide (PEI)
Number of subjects: 36
Study 1316779 — intervention group
Group type: COMPARATOR
Intervention: cisplatin, vinblastine and ifosfamide (PVI)
Number of subjects: 36
Study 3498281 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiant heat supply group (12 patients)
Number of subjects: 24
Study 3498281 — intervention group
Group type: COMPARATOR
Intervention: Combination heat supply group (12 patients)
Number of subjects: 24
Study 30045437 — intervention group
Group type: EXPERIMENTAL
Intervention: MyUM Adolescent FFQ
Number of subjects: 234
Study 30045437 — intervention group
Group type: COMPARATOR
Intervention: 7-day diet history (7DDH)
Number of subjects: 234
Study 27647052 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT)
Number of subjects: 257
Study 25194223 — intervention group
Group type: EXPERIMENTAL
Intervention: BBTI-MV (brief behavioral treatment of insomnia)
Number of subjects: 40
Study 25194223 — intervention group
Group type: COMPARATOR
Intervention: Information only control (IC)
Number of subjects: 40
Study 23720367 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation (vitamins B complex, C, and E)
Number of subjects: 201